FindTrial
Sign In

Research on the Construction of aPrecise Conversion Therapy System for Liver Metastasisof Pancreatic Cancer Based on Multimodal Data

Research on the Construction of aPrecise Conversion Therapy System for Liver Metastasisof Pancreatic Cancer Based on Multimodal Data

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125964
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver metastasis of pancreatic cancer

Interventions

Prospective cohort:NA
Retrospective cohort:NA
Organize the sample group:NA

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 18 years or above, gender not limited. 2.Diagnosis of liver metastasis from pancreatic cancer;

Exclusion criteria

Exclusion criteria: 1.Include other serious diseases and history of mental illness; 2.The researchers considered that the patients who were not suitable for inclusion in this study;

Design outcomes

Primary

MeasureTime frame
Progression-free survival;—

Secondary

MeasureTime frame
Objective response rate;Overall survival;—

Countries

China

Contacts

Public ContactYang Zhi Ying

China-Japan Friendship Hospital

yangzhy@aliyun.com+86 10 84205208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026